In 2016, New York State implemented the Medical Cannabis Program. In March 2021, the Marihuana Regulation and Taxation Act (MRTA) amended the program and improved access for medical patients with the implementation of regulations including but not limited to the expansion of qualifying medical conditions, the increase in the number of caregivers a patient may designate, and the expansion of available product categories and dispensing limits. Over the last 7 years, the Medical Program has allowed thousands of New Yorkers to gain access to safe, lab tested medical cannabis treatment and has laid the foundation for the equitable adult-use cannabis market in New York State.
Some common conditions patients use medical cannabis to find relief from include but are not limited to:
|
|